跳至主要内容
临床试验/NCT04754152
NCT04754152已完成不适用

Long-term Effect of θ Burst Magnetic Stimulation on Clinical Symptoms of Alzheimer Disease

Anhui Medical University1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2021年4月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
45
试验地点
1
主要终点
changes in Montreal Cognitive Assessment (MoCA)

研究概览

简要总结

This was a randomized, single-blind, parallel, placebo-controlled clinical trial assessing the efficacy of neuronavigational TBS among patients with AD. Fourty late-onset AD were included in the study, all the patients were divided into TBS groups and drug treatment group. Drug intervention group AD patients with drug regimen (donepezil 5mg / d) and primary care guidance, once every three months follow-up. TBS group is treated with TBS (a course of treatment every 3 months); after completing 4 treatments/follow-ups a year, evaluate the changes in MoCA, other clinical symptoms and multi-domain cognition tests, and brain Changes in structure and function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subject diagnosed with early Alzheimer's disease or related diseases according to NINCDS-ACDRADA criteria.
  • •Subjects must have a MMSE score between 10 and 27,indicating mild cognitive impairment or dementia
  • •CDR score ≤ 2
  • •Subject under treatment by IAChE for at least 3 Weeks.
  • •psychotropic treatments are tolerated if they were administered and unchanged for at least 3 months

排除标准

  • •Any history or clinical signs of other severe psychiatric illnesses (like major depression,psychosis or obsessive compulsive disorder).
  • •Page 5 of 6 [DRAFT] -
  • •History of head injury,stroke,or other neurologic disease.
  • •Organic brain defects on T1 or T2 images.
  • •History of seizures or unexplained loss of consciousness.
  • •Implanted pacemaker,medication pump,vagal stimulator,deep brain stimulator.
  • •Family history of medication refractory epilepsy.
  • •History of substance abuse within the last 6 months.

研究组 & 干预措施

TBS Group

Experimental

On the basis of drug treatment, a course of TBS treatment is performed every three months and 4 courses of treatment a year.

干预措施: θ burst transcranial magnetic stimulation (Other)

Drug Group

Placebo Comparator

Stable doses of cholinesterase inhibitors for the treatment and primary care guidance.Once every 3 months follow-up.

干预措施: Pharmacotherapy (Drug)

结局指标

主要结局

changes in Montreal Cognitive Assessment (MoCA)

时间窗: baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up

The changes in MoCA will constitute assess response to rTMS the secondary research outcome measure used to.MoCA was developed by Nasreddine et al. based on clinical experience and reference to the MMSE cognitive items and scores, and the final version was finalized in November 2004. We adopted a localized version (Mandarin version#includes 2 alternative versions) in line with the Chinese cultural background.It includes 11 inspection items in 8 cognitive fields, including visual structure skills, executive function, naming, attention and calculation, language, abstract thinking, memory, and orientation. With a total score of 30 or more than 26, it is normal. Anyone who has been education for less than 12 years will need to add one point to his final score. The final score of the higher the better, and we hope the subjects' scores will improve after treatment.

次要结局

  • The changes in MMSE(Mini Mental State Examination)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • Verbal Fluency Test-letter and semantic (VFT-L/S).(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • LMT (Logic Memory Test)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • TMT (Trail Making Test)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • The Stroop color test(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • Boston Naming Test (BNT)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • Symbol Digit Modalities Test (SDMT)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • ADL( Lawton-Brody Activities of Daily Living)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • HVOT(Hooper visual organization test Hooper visual organization test)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • HAMD (Hamilton Depression Scale)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • HAMA (Hamilton Anxiety Scale)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • NPI (Neuropsychiatric Inventory)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • DST (Digital Span Test; Forward and Backward)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • JLOT(Judgment of line Judgment of line orientation test orientation test)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • MRI measures(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)
  • Chinese version of the Auditory Verbal Learning Test (AVLT)(baseline; week-2, moth-3, month-6, month-9 and 1-year follow-up)

研究者

发起方
Anhui Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

WANG KAI

Head, Dept of Neurology & Medical Psychology, Director, Cognitive Neuropsychology Lab, PRC

Anhui Medical University

研究点 (1)

Loading locations...

相似试验